- Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19
-
Kritikou-Griva E, Chaliori I, Tsagarakis NJ, Androutsos G, Chaniotaki S, Paterakis G
- KMID: 2520578
- Blood Res.
- 2021 Sep;56(3):126-126.
- doi: 10.5045/br.2021.2021077
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
-
Nam CH, Byun JM, Shin DY, Hong J, Kim I, Yoon SS, Koh Y
- KMID: 2520615
- Blood Res.
- 2021 Sep;56(3):202-204.
- doi: 10.5045/br.2021.2021067
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma cells in disguise: the masquerader in hematopathology
-
Juneja R, Veetil KK, Pati H
- KMID: 2520579
- Blood Res.
- 2021 Sep;56(3):127-127.
- doi: 10.5045/br.2021.2021051
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes?
-
Kassir AE, Largeaud L, Vergnolle I, Oberic L, Schavgoulidze A, Rieu JB
- KMID: 2520577
- Blood Res.
- 2021 Sep;56(3):125-125.
- doi: 10.5045/br.2021.2021098
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- T cell acute lymphoblastic leukemia with t(11;14)(p13;q11) and trisomy 8
-
Safavi M, Sharari AS
- KMID: 2520580
- Blood Res.
- 2021 Sep;56(3):128-128.
- doi: 10.5045/br.2021.2021059
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report
-
Cecyn KZ, Marques MO, Rodrigues MA, Brito FN, Guimarães Baiocchi OCC
- KMID: 2520613
- Blood Res.
- 2021 Sep;56(3):197-207.
- doi: 10.5045/br.2021.2020181
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Management of COVID-19-related immune thrombocytopenia by rhTPO
-
Zhang X, Li M, Chen T, Lv D, Xia P, Qian W
- KMID: 2520617
- Blood Res.
- 2021 Sep;56(3):205-207.
- doi: 10.5045/br.2021.2020049
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
-
Anguiano-Álvarez VM, Maza-Larrea JA, Rosado-Hernández FJ, Rojas-Velasco G, Izaguirre-Ávila R
- KMID: 2520614
- Blood Res.
- 2021 Sep;56(3):201-202.
- doi: 10.5045/br.2021.2020245
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia
-
Bang SM, Na SH, Kim JH, Kim SR, Kim SR, Jang S
- KMID: 2520581
- Blood Res.
- 2021 Sep;56(3):129-133.
- doi: 10.5045/br.2021.2021126
No abstract available -
- CITED
-
- Close
- SHARE
-
- Close
- Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
-
Prakash G, Jain A, Sahu K, Bal A, Singh C, Basher R, Singh H, Mishra K, Jandial A, Lad D, Khadwal A, Srinivasan R, Das A, Varma N, Varma S, Malhotra P
- KMID: 2520582
- Blood Res.
- 2021 Sep;56(3):134-140.
- doi: 10.5045/br.2021.2021039
Background: This study evaluated the outcomes of patients with refractory/relapsed Hodgkin lymphoma (RRHL) treated with a bendamustine-based regimen in combination with ifosfamide, etoposide, and vinorelbine (VIBE). Methods: Consecutive RRHL patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- New cut-off point for D-dimer in the diagnosis of pulmonary embolism during pregnancy
-
Sadeghi S, Golshani M, Safaeian B
- KMID: 2520586
- Blood Res.
- 2021 Sep;56(3):150-155.
- doi: 10.5045/br.2021.2021069
Background: Considering that pulmonary embolism (PE) is one of the leading causes of mortality among pregnant women and that the D-dimer level in pregnancy can be highly fluctuating, a new... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical analysis of hospitalized patients with hemophilia A: single-hemophilia treatment center experience in Korea over 10 years
-
Kim JY, Park SJ, You CW
- KMID: 2520584
- Blood Res.
- 2021 Sep;56(3):141-149.
- doi: 10.5045/br.2021.2020289
Background: There is lack of data on admitted hemophilia patients in Korea. For this reason, this study was intended to analyze the hospitalization data of hemophilia patients in a regional... -
- CITED
-
- Close
- SHARE
-
- Close
- The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients
-
Shires K, Wyk TV, Wienand K
- KMID: 2520609
- Blood Res.
- 2021 Sep;56(3):156-165.
- doi: 10.5045/br.2021.2020335
Background It is thought that cancer/testis antigens (CTAs) are expressed in a cascade-like manner in multiple myeloma as the disease progresses. In this pilot study, we investigated the co-expression of several... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
-
Chong SL, Ahmad Asnawi AW, Leong TS, Tan JT, Law KB, Hon SL, Fann RJ, Tan SM
- KMID: 2520611
- Blood Res.
- 2021 Sep;56(3):175-183.
- doi: 10.5045/br.2021.2021045
Background With the emergence of tyrosine kinase inhibitors and the incorporation of stringent measurable residual disease (MRD) monitoring, risk stratification for BCR-ABL1-positive acute lymphoblastic leukemia (ALL) patients has changed significantly. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study
-
Park SS, Kim HJ, Kim TY, Lee Jy, Lee JH, Min GJ, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim DW
- KMID: 2520612
- Blood Res.
- 2021 Sep;56(3):184-196.
- doi: 10.5045/br.2021.2021107
Background Allogeneic hematopoietic stem cell transplantation (alloSCT) is a potentially curative treatment option for acute leukemia. We aimed to identify the comorbidity factors affecting survival outcomes after alloSCT and develop a... -
- CITED
-
- Close
- SHARE
-
- Close
- Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City
-
Olivas-Martinez A, Corona-Rodarte E, Nuñez-Zuno A, Barrales-Benítez O, Montante-Montes de Oca D, Delgado-de la Mora J, León-Aguilar D, Hernández-Juárez HE, Tuna-Aguilar E
- KMID: 2520610
- Blood Res.
- 2021 Sep;56(3):166-174.
- doi: 10.5045/br.2021.2021111
Background Thrombotic events are well documented in primary erythrocytosis, but it is uncertain if secondary etiologies increase the risk of thrombosis. This study aimed to determine the causes of erythrocytosis and... -
- CITED
-
- Close
- SHARE
-
- Close
